Alto Neuroscience (ANRO) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.8
-0.71
-0.61
-0.52

Details

Expected EPS
-0.536364
Actual EPS
-0.8
Surprise EPS
-0.26
Surprise Percent
+49.15%

Description

Alto Neuroscience (ANRO) has reported earnings of -0.8 per share for Q2 2026.

0 Comments

Share your thoughts